<DOC>
	<DOCNO>NCT02020980</DOCNO>
	<brief_summary>The objective study demonstrate effect intramuscular BoNT-A injection relieve pain , broad population patient suffer pain primary problem associate spasticity . Thus , study help expand information available regard impact BoNT-A treatment routine clinical practice condition . Treatment goal vary greatly one patient another unique , single outcome reflect treatment benefit case . Therefore , study special focus achievement therapeutic goal , allow identification patient 's specific goal regard improvement functional outcome , quality life patient well-being .</brief_summary>
	<brief_title>RELIEF Study : Lower Limb Pain Relief After Injection Cycles Adults Suffering From Lower Limb Spasticity Following Stroke</brief_title>
	<detailed_description />
	<mesh_term>Muscle Spasticity</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Men woman age 18 year Poststroke lowerlimb spasticity Prior agreement patient inject BoNTA If previously treat BoNTA , ( least 3 month interval last injection inclusion ) . Therapeutic goal agree jointly patient Functional Ambulation Classification ( FAC ) score 25 Capacity comply protocol Written inform consent Documented positive antigenicity botulinum toxin Neuromuscular disease Use medication interfere neuromuscular transmission Severe muscle atrophy muscle inject Any indication might interfere rehabilitation evaluation result Any nonstroke spasticity diagnosis Pregnancy nursing mother Previous participation study use Goal Attainment Scale ( GAS )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>